Management of primary neuroendocrine tumour of the breast | Zendy

Divya Dahiya | Zendy; Budhi Singh Yadav | Zendy; Lileswar Kaman | Zendy; Kim Vaiphei | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of primary neuroendocrine tumour of the breast

Author(s) -

Divya Dahiya,

Budhi Singh Yadav,

Lileswar Kaman,

Kim Vaiphei

Publication year - 2019

Publication title -

sri lanka journal of surgery/sri lanka journal of surgery

Language(s) - English

Resource type - Journals

eISSN - 2279-2201

pISSN - 0379-8240

DOI - 10.4038/sljs.v37i3.8613

Subject(s) - medicine , medical journal , sri lanka , alternative medicine , library science , medical education , family medicine , tanzania , pathology , sociology , ethnology , computer science

Primary neuroendocrine tumour (NET) of the breast is a rare entity and constitutes less than 1% of all breast cancers [1]. The World Health Organization (WHO) defined mammary neuroendocrine carcinoma (NEC) as a separate entity in 2003 and revised the term NEC in 2012 to carcinoma with neuroendocrine differentiation [2]. Unlike infiltrating duct carcinoma (IDC), clinical features, and biological behaviour of NET of the breast is not well understood. In the absence of any large series, the optimal treatment is uncertain and they are treated as other invasive tumours of the breast. Therefore, this study aimed to analyze the outcome of surgery among patients with NET of breast.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research